Next Article in Journal
How Official Social Media Affected the Infodemic among Adults during the First Wave of COVID-19 in China
Previous Article in Journal
Association between Thyroid Cancer and Weight Change: A Longitudinal Follow-Up Study
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Epidemiological Study of Risk Factors for Lung Cancer in KwaZulu-Natal, South Africa

by
Noluthando P. Mbeje
1,2,*,
Themba Ginindza
1,2 and
Nkosana Jafta
1,3
1
Cancer and Infectious Diseases Epidemiology Research Unit, College of Health Sciences, University of KwaZulu-Natal, Durban 4041, South Africa
2
Discipline of Public Health Medicine, School of Nursing and Public Health, College of Health Sciences, University of KwaZulu-Natal, Durban 4041, South Africa
3
Discipline of Occupational and Environmental Health, School of Nursing and Public Health, College of Health Sciences, University of KwaZulu–Natal, Durban 4041, South Africa
*
Author to whom correspondence should be addressed.
Int. J. Environ. Res. Public Health 2022, 19(11), 6752; https://doi.org/10.3390/ijerph19116752
Submission received: 12 May 2022 / Revised: 27 May 2022 / Accepted: 27 May 2022 / Published: 31 May 2022

Abstract

:
The high incidence cancer rates are due to factors such as behavior, occupational exposures, genetics, environmental pollution and infections. The aim of this study was to identify risk factors associated with lung cancer among patients seen in the public health facilities in KwaZulu-Natal, South Africa. In this case-control study, 75 cases and 159 controls were interviewed using a structured close-ended questionnaire. Logistic regression showed a positive association between lung cancer and tobacco smoking (OR = 2.86, 95% CI: 1.21–6.77) and exposure to passive smoke (OR = 3.28, 95% CI: 1.48–7.30). When adjusted for other covariates, tobacco smoking and passive smoke were still positively associated with increased risk of lung cancer. Alcohol consumption (aORs ranging from 2.79 to 3.35) and history of lung disease (aORs ranging from 9.91 to 12.1) were statistically significantly associated with lung cancer. Our study suggests that tobacco smoke exposure is the major cause of lung cancer, and increased exposure to occupational and environmental carcinogenic substances, alcohol consumption and history of lung disease increase the risk of lung cancer. Based on our findings, policy development and planning of prevention strategies incorporating smoking legislations, occupational health and safety are essential in South Africa.

1. Introduction

Globally, lung cancer is the most common cancer and has one of the poorest prognoses and highest mortality rates [1], and this has resulted in it being the leading cause of cancer death (18.4% of the total cancer deaths) with 1.8 million related lung cancer deaths in 2018 [2]. Cancer morbidity and mortality are associated with factors such as behavior, occupational exposures, genetics, environmental pollution and infections [2,3].
Lung cancer mortality in South Africa is high [4] with the age standardized incidence rate (ASR) 8.37/100,000 for males and 3.57/100,000 for females [5]. Prior studies on lung cancer in South Africa indicate that the lung cancer mortality rate is high [4,6]. Other studies indicate the need for screening and management of lung cancer patients. According to Eeden et al., smoking is the main risk factor for lung cancer; however, data on smoking prevalence need to be updated [6]. Other risk factors associated with lung cancer were identified in this study.
The association between tobacco smoking and lung cancer is well established [7,8], with some studies attributing approximately 80% of global lung cancer mortality to tobacco smoking [7,9]. Secondhand smokers are also at risk for lung cancer [4]. It is estimated that approximately 15% of lung cancer cases are people that are light smokers or never smoked [10]; therefore, there are more risk factors associated with lung cancer other than smoking [11]. Fifteen percent (15%) of global lung cancer mortality is attributed to occupational risk factors such as asbestos and silica [12].
A systematic review and meta-analysis by Ngamwong et al. found that the combination of tobacco smoking and asbestos exposure causes lung cancer through an additive mechanism [13]. Another study found that lung cancer risk in individuals who are tobacco smokers diagnosed with chronic obstructive pulmonary disease (COPD) was more than 11-fold higher compared to individuals that only smoke [14]. A meta-analysis involving 31 studies found a 2-fold increased risk of lung cancer in persons with a family history of lung cancer with most of them being nonsmokers [15].
In Africa, cancer is a cumulatively persisting challenge due to the aging and growth of the population, as well as the increasing prevalence of risk factors [16]. The prevalence of smoking tobacco has increased to 37% for males and significantly dropped to 8% for 57 women aged 15 and older [17]. The South African demographic and health survey indicated that among smokers, most smokers smoke cigarettes on a daily basis at 30% for males and 6% for females [17]. The objective of the study was to identify and quantify risk factors of lung cancer amongst patients seen in the public health facilities in KwaZulu-Natal, South Africa.

2. Materials and Methods

2.1. Study Setting and Population

This was a case-control designed study with a ratio of 1:2, conducted from January 2018 to March 2019. The participants were recruited from the three public health facilities that provide oncology services in the province of KwaZulu-Natal, South Africa, namely: Addington Hospital, Greys Hospital and Inkosi Albert Luthuli Central Hospital (IALCH).

2.2. Identification and Recruitment of Participants

Cases were patients with the lung cancer diagnosis that was laboratory confirmed through a biopsy, X-ray, CT Scan and cytology, and/or clinical investigations. All the details regarding cancer diagnoses, stage, comorbidities and other exposure were self-reported during patient interviews. The cases were recruited at the oncology clinic during the patient’s lung cancer treatment appointment at the three public health facilities. The cases had to be patients that were diagnosed with cancer for the first time (primary cancer), and those that had a previous diagnosis of cancer were excluded.
In the same health facilities, controls were recruited from the outpatient clinics and patient wards of the orthopedics departments. The controls were patients that had not been diagnosed with cancer before and had no signs and symptoms similar to those of lung cancer or respiratory illness at the time of the study. The controls were screened by asking questions on lung cancer symptoms or signs such as unexplained cough, shortness of breath or whizzing, blood sputum, chest pains and difficulty in swallowing.

2.3. Data Collection Using Questionnaire

After obtaining consent, the participants were interviewed using a structured close-ended questionnaire made up of questions that inquire about the patient’s demographics, the diagnosis and different exposures and risk factors associated with lung cancer. The information collected on diagnosis included lung cancer symptoms and/or signs (unexplained cough, blood sputum, shortness of breath/whizzing, hoarseness of voice, chest pains, unexplained weight-loss); date and age at diagnosis; name of facility where the cancer was diagnosed; method of cancer diagnoses, cancer treatment and referral process were also collected. Information on other diseases such as high blood pressure, pneumonia, chronic bronchitis, asthma and infectious disease such as HIV/AIDS and tuberculosis was also covered. Family history information on any family member of the participant that had been diagnosed with any type of cancer was also collected. With regards to information on occupational history and exposure to likely carcinogenic substances, we collected information on industry and type of work, duration at the company, how participants were exposed to different substances and use of protective personal equipment. Additional information on personal habits and behaviors such as smoking tobacco (cigarette) and exposure to passive smoke at home and/or the workplace and use of alcohol was also collected (Figure 1). The questionnaires were either administered face-to-face or by telephone in isiZulu or English at a time convenient for the participants.

2.4. Data Analysis

All completed questionnaires were captured on the REDCap database (REDCap v8.11.7, Vanderbilt University, TN, USA). Thereafter, data were checked and corrected for possible errors prior to analysis. Of the recruited 79 cases and 160 controls, four cases and one control were excluded from data analysis due to previous participants’ history of cancer diagnosis, therefore leaving 234 participants (75 lung cancer cases and 159 controls) (Figure 2). Data were then transferred from REDCap to Stata IC version 13 (StataCorp, College Station, TX, USA) for further analysis.
The characteristics of lung cancer cases and controls participating in the study, namely, the age, gender, race, education and socioeconomic, were described using descriptive statistics. Passive smoke in this study was defined as exposure to cigarette smoke at home (someone smoking inside the house) and in the workplace. History of lung disease was categorized as positive if the participants had been diagnosed with tuberculosis, asthma, pneumonia or chronic bronchitis. The occupations or industries that the participants were working in or have worked in were grouped according to the Statistics South Africa (Stats-SA) Industry code list. Industry 1—clerical support, services and sales, elementary occupation (Stats-SA code: 61, 62,64, 81–84, 93–99); Industry 2—transport and repair of motor vehicles (Stats-SA code: 63, 71–75), Industry 3—mining, construction, manufacturing (Stats-SA code: 21–50); and Industry 4—skilled agriculture, hunting, forestry/fishing (Stats-SA code:11–13) [18].
The differences in characteristics between cases and controls were tested using simple logistic regression. Associations between the risk factors and lung cancer were assessed using multivariable logistic regression. We ran six models; two models were for environmental exposures, and four models were for occupational exposures. The first models were on smoking and passive smoke. The second set of models we ran was on occupational and carcinogen exposures; these models included smoking as a covariate. The four models on occupational exposure had different independent variables/indicators, namely, (1) office and household; (2) transport and repair of motor vehicles; (3) mining, construction, all types of manufacturing; (4) agriculture, hunting, forestry/fishing as per the classification of Stats-SA. Significant covariates in the univariate model and/or those that were indicated by the literature to be confounders were selected a priori for inclusion in the models. Variables such as age, gender, race, marital status and education were included into all the models regardless of the significance in the univariate analysis.

2.5. Ethical Considerations

The study was approved by the University of KwaZulu-Natal’s Biomedical Research Ethics Committee (BREC) (Ref: BE533/18) and the province of the KwaZulu-Natal Department of Health (Ref: HRKM0007/18 (KZ_201B01_013)). Permission to conduct the study was also granted by the three public health facilities at which the lung cancer risk factors questionnaires were administered. All potential participants were informed about the study in their preferred language (in isiZulu or English) and were given an information sheet explaining the study. Consents were obtained from participants who agreed to be part of the study before the questionnaires were administered.

3. Results

Demographic characteristics of 234 participants (75 cases and 159 controls) are shown in Table 1. Among the recruited study participants, for both cases and controls, males were of a higher proportion at 64.0% and 60.4%, respectively. The mean (SD) age was higher for the cases at 61.8 (13.9) years than for the controls at 54.8 (14.4) years. The majority of the cases were married (57.5%), whereas the majority of the controls were single (44.5%). Approximately 70% of participants had an educational level ranging between high school to higher education. A higher proportion of the cases (71%) and controls (74%) had a monthly household income of R0 to R4000.
For the lung cancer cases, biopsy was the most commonly used basis of diagnosis at 74.7% (n = 56). The stage of lung cancer was unknown for more than half (58.7%, n = 44) of the cancer cases. For the cancer cases that were staged, stage 4 was the most prevalent at 37.3% (n = 28). According to our data (Table 2), 65.3% (n = 49) of the cases were tobacco smokers, and 54.7% (n = 41) of the cases reported that they were exposed to passive smoke either at home or in the workplace.
A first-degree relative family history of cancer was crudely associated with increased risk of lung cancer in siblings by 8-fold (unadjusted OR 8.93 (95% CI: 2.41–33.1; p = 0.001), but for biological parents this was not the case. History of lung disease (tuberculosis and asthma) was crudely associated with lung cancer by more than 7-fold (unadjusted OR 7.83 (95% CI 3.29 –18.7; p < 0.001).
More cases vs. controls were exposed to soot (9.33% vs. 1.26%) and iron and steel (10.7% vs. 1.26%), and there was an unadjusted increased risk of OR = 8.08 (95% CI: 1.64–39.91; p = 0.010) and OR = 9.37 (95% CI: 1.94–45.31; p = 0.005), respectively. Environmental asbestos exposure, occupational asbestos exposure, radon were not statistically associated with lung cancer but were positively associated at OR = 1.08 (95% CI: 0.58–2.02; p = 0.805), OR = 1.53 (95% CI: 0.56–4.20; p = 0.405) and OR = 4.33 (95% CI: 0.39–48.5; p = 0.235), respectively.
Table 3 contains results of multivariable logistic regression showing a positive association of lung cancer for tobacco smoking and exposure to passive smoke. After adjusting for covariates, tobacco smoking (aOR = 2.86, 95% CI: 1.21–6.77; p = 0.017) and passive smoke (aOR = 3.28, 95% CI: 1.48–7.30; p = 0.004) were still positively associated with an increased risk among cases when compared to people not exposed to tobacco; alcohol consumption (aORs ranging from 2.79 to 3.35) and history of lung disease (aORs ranging from 9.91 to 12.1) were significantly associated with lung cancer in the multivariable logistic models.
Working in mining, construction and manufacturing was a significant risk factor even after adjusting covariates (aOR = 2.64, 95% CI: 1.16–6.01; p = 0.020), although the risk was amplified compared to when it was not adjusted (OR = 2.15, 95% CI: 1.22–3.79). Increased unadjusted risk of lung cancer was observed in participants with a history of working in transport, storage, repair of motor vehicles (OR = 3.05, 95% CI: 1.38–6.72; p = 0.006) and after adjusting covariates (aOR = 1.63, 95% CI: 0.54–4.94; p = 0.006). After adjusting for other variables, the risk of lung cancer was lower and not significantly associated with an increase in the office and household workplace when compared to other occupations (Table 4).

4. Discussion

In this study, tobacco smoking and passive smoke exposure were associated with an increased risk of lung cancer. Alcohol consumption, history of lung disease and occupations with exposure to soot, iron and steel were also associated with having lung cancer.
Exposure to tobacco smoke is a well-established risk factor for lung cancer [7,19], and, in this study, exposure to both tobacco smoking and passive smoke at home or work were associated with a significantly increased risk of lung cancer. Lung cancer risk is estimated to be 20-fold for people that smoke cigarettes, and this risk increases with the duration and quantity consumed [7]. In this study we did not quantify smoking or characterize it in detail, but measurement by reporting use for tobacco was adequate. Exposure to passive smoke is also a well-known risk factor for lung cancer, which has been shown in the past few decades [20].
Tar found in cigarettes has approximately 3500 different compounds in it, and approximately 60–70 of the chemicals found in cigarettes are classified as carcinogens, 1,3-butadiene, ethyl carbonate and arsenic, just to name a few [19,21]. Some of the compounds in tobacco are either carcinogenic or they need to be metabolically activated [19,21]. These compounds are oxygenated by cytochrome P450 enzymes, which can result in DNA adducts that start a process of carcinogenesis [22,23]. All the different DNA adducts that are not repaired by the DNA repair mechanism can lead to the development of lung cancer [21,23].
Epidemiological studies have reported an inconsistent association between the risk of lung cancer and alcohol [7], and this study found that alcohol was a significant positive determinant of lung cancer. According to a review by Bandera et al., two case-control studies and three cohort studies found a significant dose-response association of total alcohol intake and lung cancer [24]. The risk estimates of the association ranged from the relative risk (RR) of 1.6 to 2.2 for more than 41 to 176 mL of drinks per week of pure ethanol per day (approximately 3000 mL of beer per day) [24,25,26]. Other studies have found that even consuming one glass of alcohol per day has the potential to increase the risk of lung cancer in both males and females (RR-1.23, 95%CI, 1.06–1.41). The mechanism of alcohol and lung cancer is not well established in humans; however, the studies on animals showed that ethanol increases the risk of lung cancer through the primary oxidative metabolism mechanism [24,27]. Rats that were used in experiments and those exposed to alcohol showed DNA damage [27]. Another study conducted by Fang and Vaca found that acetaldehyde, a first metabolite of ethanol oxidation, is mutagenic and carcinogenic in animal experiments, therefore compounding the risk by increasing DNA adducts in peripheral blood cells among alcoholics [28].
However, several studies indicate that lung cancer can also develop in never smokers [29,30,31] which means there are other risk factors that contribute to lung cancer. Lo et al. listed exposure to radon, passive smoke, occupational carcinogens and history of lung disease as some of the risk factors for lung cancer in patients that have never smoked [31]. Some of these exposures were also found to be positively associated with lung cancer in this study. This study found a higher lung cancer incidence in males than females, which is consistent with literature [2]. The most commonly and well-established risk could be that more men than women smoke tobacco and are exposed to occupational carcinogens [7,19]. Literature indicates that women are more likely to be exposed to the cooking fumes and indoor air pollution [32].
History of lung disease was found to be associated with lung cancer, and this is in line with other studies [14,33]. According to these studies, the people with a history or pre-existing lung disease such as tuberculosis (TB) and asthma are at a higher risk for lung cancer [33]. Young et al. reported a 5-fold (OR) increased risk for people with a history of lung disease and smoking compared to people who only smoke and do not have a history of lung disease [14]. The risk of TB is postulated to be through biological mechanisms where prolonged pulmonary inflammation leads to tissue damage, fibrosis, scars forming in the lungs and genomic damages [34]. Due to this inflammation and scarring that is associated with TB, it is possible that TB plays a role as either the initiator or promoter of lung cancer [35]. Another alternate explanation of this association of lung cancer with TB is the misdiagnosis of lung cancer for TB because of similar pulmonary symptoms and presentation [36]. Studies indicate that those with a lung cancer diagnosis are first diagnosed as TB before lung cancer [37,38] with one study having an incidence of 14.6% of patients with misdiagnosis of lung cancer as TB [36]. The misdiagnosis delays the cancer diagnosis therefore influencing prognosis.
This study found that occupations such as manufacturing and agriculture increased the risk of lung cancer which is a finding consistent with the literature [39,40]. We found that occupations that result in exposure to particulates and fumes such as in mining, construction and iron and steel increased the risk of lung cancer compared to people not exposed. For individuals that work in mines, the risk of lung cancer is increased by the exposure to inorganic metals in the form of fumes, alloy and hexavalent compounds [7,41] (4,29). Recent epidemiological evidence indicates a higher and increased lung cancer risk among stainless steel welders compared to mild steel welding workers [39]. This could be caused by the different quantity in toxicity of the welding fumes [42]. Men that were employed at baseline as welders were associated with a 16% increased risk of lung cancer. The risk was greater for welders in the vehicle repair industry at 40% greater than non-welders. These employees were exposed to carcinogenic exposures such as iron-containing steel, chromium, nickel and aluminum [39].
A positive association of lung cancer with exposure to asbestos and radon was found in this study; however, the association was not statistically significant. The literature shows asbestos as a widely known substance associated with lung cancer in occupational settings [43]. Individuals that work in construction are exposed to a mixture of risk factors such as asbestos and other fibers, painting and chemicals. Asbestos is used in construction building, and the association of asbestos and lung cancer is well established [7]. Painting has been associated with 40% excess risk of lung cancer; this is due to painters being exposed to hydrocarbon and chlorinated solvents, dyes, polyesters, phenol-formaldehyde and polyurethane resins [7]. Lung cancer is a disease, and the exposures associated with it may have complex interactions within the host.
The strength of this study is that exposure data to risk factors were collected directly from the participants and not through the medical records, therefore allowing a better characterization of exposure. Secondly, the cases and controls were selected from the same health facilities which reduced selection bias because participants are more likely to come from similar communities with a comparable socioeconomic status. Limitations in our study were that the sample size was likely to have been influenced by the high mortality rate of lung cancer because of late presentation to the health facilities, therefore missing a group of patients such as those who are living far from these treatment centers. The number of cases that had a histologic classification was limited due to missing data on the patients’ medical records and the basis of diagnosis used for the lung cancer patients. Further investigation on data collection needs to be conducted in the future to ensure that all the clinical data are recorded in the patient file.

5. Conclusions

This study provides insight into the epidemiological risk factors of lung cancer in the population of KwaZulu-Natal. The study suggests that although tobacco smoking and passive smoke exposure are major risk factors of lung cancer, increased exposure to some occupational and environmental substances may increase the risk of developing lung cancer. Alcohol consumption and history of lung disease are also important risk factors for lung cancer. The control of tobacco smoking, exposure to passive smoke and carcinogens are important for lung cancer prevention. Therefore, there is a need for the strengthening of the tobacco production policy and occupational health and safety policy, and for the expanding of lung cancer prevention and screening programs.

Author Contributions

N.P.M., N.J. and T.G. conceptualized and designed the study. N.P.M. carried out data collection and analyses, and wrote the paper. N.P.M., N.J. and T.G. analyzed data and supervised writing up the manuscript. All authors have read and agreed to the published version of the manuscript.

Funding

The study was funded by the Bristol-Myers Squibb Foundation (Grant #1011) under the Multinational Lung Cancer Control Program (MLCCP). The funders had no role in the study design, data collection and analysis, decision to publish.

Institutional Review Board Statement

The study was approved by the University of KwaZulu-Natal’s Biomedical Research Ethics Committee (BREC) (Ref: BE533/18) and the province of the KwaZulu-Natal Department of Health (Ref: HRKM0007/18 (KZ_201B01_013)). Permission was also granted by the three public health facilities at which the lung cancer risk factors questionnaires were administered. All potential participants were informed about the study in their preferred language (in isiZulu or English) and were given an information sheet explaining the study.

Informed Consent Statement

Consents were obtained from participants who agreed to be part of the study before the questionnaires were administered.

Data Availability Statement

Data from this study are the property of the KwaZulu-Natal Department of Health (KZN DOH) and the University of KwaZulu-Natal and cannot be made publicly available. All interested readers can access the data set from the DOH Research ethics committee and the University of KwaZulu-Natal Biomedical Research Ethics Committee (BREC) from the following contacts: The Health Research and Knowledge Management, 330 Langalibalele Street, Private bag X9051, Pietermaritzburg, 3200, Tel.: +27-33-3952805 Fax: +27-33-3943782 Email: [email protected] The Chairperson Biomedical Research Ethics Administration Research Office, Westville Campus, Govan Mbeki Building University of KwaZulu-Natal P/Bag X54001, Durban, 4000 KwaZulu-Natal, South Africa Tel.: + 27-31-2604769 Fax: + 27-31-2604609 Email: [email protected].

Acknowledgments

We wish to thank the patients who participated in the study and the community caregivers who assisted with data collection. We would like also to thank the MLCCP team, University of KwaZulu-Natal School of Nursing and Public Health Medicine and KZN Department of Health and all the public health institutions (Addington Hospital, Greys Hospital and Inkosi Albert Luthuli Central Hospital) that allowed us to carry out the research.

Conflicts of Interest

All the authors have declared that there are no conflicts of interest.

Abbreviations

IARCInternational Agency for Research on Cancer
KZNKwaZulu-Natal
OROdds Ratio
WHOWorld Health Organization
Stats-SAStatistics South Africa

References

  1. Arkin, D.M.P.; Ray, F.B.; Erlay, J.F.; Isani, P.P. Estimating the world cancer burden: Globocan 2000. Int. J. Cancer 2001, 94, 153–156. [Google Scholar] [CrossRef] [PubMed]
  2. Bray, F.; Ferlay, J.; Soerjomataram, I.; Siegel, R.L.; Torre, L.A.; Jemal, A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA. Cancer J. Clin. 2018, 68, 394–424. [Google Scholar] [CrossRef] [Green Version]
  3. Hashim, D.; Boffetta, P. Occupational and environmental exposures and cancers in developing countries. Ann. Glob. Health 2014, 80, 393–411. [Google Scholar] [CrossRef] [PubMed]
  4. Koegelenberg, C.F.N.; Society, O.B.O.T.S.A.T.; Dorfman, S.; Schewitz, I.; Richards, G.A.; Maasdorp, S.; Smith, C.; Dheda, K. Recommendations for lung cancer screening in Southern Africa. J. Thorac. Dis. 2019, 11, 3696–3703. [Google Scholar] [CrossRef]
  5. Luis, F.; Moncayo, G. NCR Pathalogy 2018 Full Report 1; National Health Laboratory Service: Johannesburg, South Africa, 2021; pp. 1–38. [Google Scholar]
  6. van Eeden, R.; Tunmer, M.; Geldenhuys, A.; Nayler, S.; Rapoport, B.L. Lung Cancer in South Africa. J. Thorac. Oncol. 2020, 15, 22–28. [Google Scholar] [CrossRef]
  7. WHO-IARC; Stewart, B.W.; Kleihues, P. World Cancer Report; IACR: Lyon, France, 2003. [Google Scholar]
  8. Khuder, S.A. Effect of cigarette smoking on major histological types of lung cancer: A meta-analysis. Lung Cancer 2001, 31, 139–148. [Google Scholar] [CrossRef]
  9. WHO-IARC. Monographs on the Evaluation of Carcinogenic Risks to Humans. Tobacco Smoke and Involuntary Smoking; IACR: Lyon, France, 2004; Volume 83. [Google Scholar]
  10. Inoue-Choi, M.; Hartge, P.; Liao, L.M.; Caporaso, N.; Freedman, N.D. Association between long-term low- intensity cigarette smoking and incidence of smoking-related cancer in the National Institutes of Health-AARP cohort. Int. J. Cancer 2018, 142, 271–280. [Google Scholar] [CrossRef]
  11. Jafri, S.H.; Ali, F.; Mollaeian, A.; Hasan, S.M.; Hussain, R.; Akkanti, B.; Williams, J.; Shoukier, M.; El-Osta, H.; Akanti, B. Major Stressful Life Events and Risk of Developing Lung Cancer: A Case-Control Study. Clin. Med. Insights Oncol. 2019, 13, 117955491983579. [Google Scholar] [CrossRef]
  12. Driscoll, T.; Nelson, D.I.; Steenland, K.; Leigh, J.; Concha-Barrientos, M.; Fingerhut, M.; Prüss-Üstün, A. The global burden of disease due to occupational carcinogens. Am. J. Ind. Med. 2005, 48, 419–431. [Google Scholar] [CrossRef]
  13. Ngamwong, Y.; Tangamornsuksan, W.; Lohitnavy, O.; Chaiyakunapruk, N.; Scholfield, C.N.; Reisfeld, B.; Lohitnavy, M. Additive synergism between asbestos and smoking in lung cancer risk: A systematic review and meta-analysis. PLoS ONE 2015, 10, e0135798. [Google Scholar] [CrossRef]
  14. Young, R.P.; Hopkins, R.J.; Christmas, T.; Black, P.N.; Metcalf, P.; Gamble, G.D. COPD prevalence is increased in lung cancer, independent of age, sex and smoking history. Eur. Respir. J. 2009, 34, 380–386. [Google Scholar] [CrossRef] [Green Version]
  15. Matakidou, A.; Eisen, T.; Houlston, R.S. Systematic review of the relationship between family history and lung cancer risk. Br. J. Cancer 2005, 93, 825–833. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  16. Parkin, D.M.; Bray, F.; Ferlay, J.; Jemal, A. Cancer in Africa 2012. Cancer Epidemiol. Biomark. Prev. 2014, 23, 953–966. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  17. (NDoH) National Department of Health; (Stats SA) Statistics South Africa; (SAMRC) South African Medical Research Council; ICF. South Africa Demographic and Health Survey 2016; National Department of Health: Cape Town, South Africa, 2019. [Google Scholar]
  18. Stats, S.A. Census. 2001. Available online: http://www.statssa.gov.za/?page_id=4519 (accessed on 14 July 2019).
  19. Smith, C.J.; Perfetti, T.A.; Rumple, M.A.; Rodgman, A.; Doolittle, D.J. ‘IARC Group 2B carcinogens’ reported in cigarette mainstream smoke. Food Chem. Toxicol. 2001, 39, 183–205. [Google Scholar] [CrossRef]
  20. Kim, A.; Ko, H.; Kwon, J.; Lee, J. Exposure to secondhand Smoke and risk of cancer in never smokers: A meta-analysis of epidemiologic studies. Int. J. Environ. Res. Public Health 2018, 15, 1981. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  21. Akhtar, N.; Bansal, J.G. Risk factors of Lung Cancer in nonsmoker. Curr. Probl. Cancer 2017, 41, 328–339. [Google Scholar] [CrossRef] [PubMed]
  22. Furge, L.L.; Guengerich, F.P. Mini-series: Modern metabolic concepts cytochrome P450 enzymes in drug metabolism and chemical toxicology. Biochem. Mol. Biol. Educ. 2006, 3, 66–74. [Google Scholar] [CrossRef]
  23. Massion, P.P.; Sequist, L.V.; Cancer, L. Biology of lung cancer. In Neoplasms of the Lung; Elsevier Health Sciences: Amsterdam, The Netherlands, 2017; pp. 912–926. [Google Scholar]
  24. Bandera, E.V.; Freudenheim, J.L.; Vena, J.E. Alcohol Consumption and Lung Cancer: A Review of the Epidemiologic Evidence. Am. Assoc. Cancer Res. 2001, 10, 813–821. [Google Scholar]
  25. Carpenter, C.L.; Morgenstern, H.; London, S.J. Alcoholic Beverage Consumption and Lung Cancer Risk among Residents of Los Angeles County 1–6. Am. Soc. Nutr. Sci. 1998, 128, 694–700. [Google Scholar] [CrossRef]
  26. Grønbaek, M.; Jensen, M.K.; Johansen, D.; Becker, U. Intake of beer, wine and spirits and risk of heavy drinking and alcoholic cirrhosis. Biol. Res. 2004, 37, 195–200. [Google Scholar] [CrossRef] [Green Version]
  27. Nachiappan, V.; Si, M.; Chakravarti, A.; Cd, E.; Rajasekharan, R. Lipid peroxidation and ethanol-related tumor promotion in Fischer- 344 rats treated with tobacco-specific nitrosamines. Alcohol Alcohol. 1994, 29, 7811340. [Google Scholar]
  28. Fang, J.; Vaca, C.E. Detection of DNA adducts of acetaldehyde in peripheral white blood cells of alcohol abusers. Carcinogenesis 1997, 18, 627–632. [Google Scholar] [CrossRef]
  29. Corrales, L.; Rosell, R.; Cardona, A.F.; Martín, C.; Zatarain-Barrón, Z.L.; Arrieta, O. Lung cancer in never smokers: The role of different risk factors other than tobacco smoking. Crit. Rev. Oncol. Hematol. 2020, 148, 102895. [Google Scholar] [CrossRef] [PubMed]
  30. Siegel, D.A.; Fedewa, S.A.; Henley, S.J.; Pollack, L.A.; Jemal, A. Proportion of Never Smokers among Men and Women with Lung Cancer in 7 US States. JAMA Oncol. 2021, 7, 302–304. [Google Scholar] [CrossRef] [PubMed]
  31. Lo, Y.-L.; Hsiao, C.-F.; Chang, G.-C.; Tsai, Y.-H.; Huang, M.-S.; Su, W.-C.; Chen, Y.-M.; Hsin, C.-W.; Chang, C.-H.; Yang, P.-C.; et al. Risk factors for primary lung cancer among never smokers by gender in a matched case-control study. Cancer Causes Control 2013, 24, 567–576. [Google Scholar] [CrossRef]
  32. Couraud, S.; Zalcman, G.; Milleron, B.; Morin, F.; Souquet, P.-J. Lung cancer in never smokers—A review. J. Clin. Oncol. 2017, 5, 561–570. [Google Scholar] [CrossRef] [PubMed]
  33. Brenner, D.R.; Boffetta, P.; Duell, E.J.; Bickeböller, H.; Rosenberger, A.; McCormack, V.; Muscat, J.E.; Yang, P.; Wichmann, H.-E.; Brueske-Hohlfeld, I.; et al. Previous lung diseases and lung cancer risk: A pooled analysis from the international lung cancer consortium. Am. J. Epidemiol. 2012, 176, 573–585. [Google Scholar] [CrossRef]
  34. Nalbandian, A.; Yan, B.; Pichugin, A.; Bronson, R.T.; Kramnik, I. Lung carcinogenesis induced by chronic tuberculosis infection: The experimental model and genetic control. Oncogene 2009, 28, 1928–1938. [Google Scholar] [CrossRef] [Green Version]
  35. Gomperts, B.; Spira, A.; Massion, P.; Walser, T.; Wistuba, I.; Minna, J.; Dubinett, S. Evolving concepts in lung carcinogenesis. Natl. Inst. Health 2012, 32, 32–43. [Google Scholar] [CrossRef] [Green Version]
  36. Shu, C.; Chang, S.; Lai, Y.; Chang, C. Factors for the early revision of misdiagnosed Tuberculosis to lung cancer: A multicenter study in a Tuberculosis-prevalent area. J. Clin. Med. 2019, 8, 700. [Google Scholar] [CrossRef] [Green Version]
  37. Parker, C.S.; Siracuse, C.G.; Litle, V.R. Identifying lung cancer in patients with active pulmonary tuberculosis. J. Thorac. Dis. 2018, 10, 3392–3397. [Google Scholar] [CrossRef]
  38. Hammen, I. Tuberculosis mimicking lung cancer. Respir. Med. Case Rep. 2015, 16, 45–47. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  39. MacLeod, J.S.; Harris, M.A.; Tjepkema, M.; Peters, P.A.; Demers, P.A. Cancer risks among welders and occasional welders in a national population-based cohort study: Canadian census health and environmental cohort. Saf. Health Work 2017, 8, 258–266. [Google Scholar] [CrossRef]
  40. IARC. IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man; ICAR: Lyon, France, 1973; Volume 2, pp. 17–47. [Google Scholar]
  41. International Agency for Research on Cancer (IARC). IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Chromium, Nickel and Welding; IARC: Lyon, France, 1990; Volume 49, p. 677. [Google Scholar]
  42. Leonard, S.S.; Chen, B.T.; Stone, S.G.; Schwegler-Berry, D.; Kenyon, A.J.; Frazer, D.; Antonini, J.M. Comparison of stainless and mild steel welding fumes in generation of reactive oxygen species. Part. Fibre Toxicol. 2010, 7, 32. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  43. Jones, R.N.; Hughes, J.M.; Weill, H. Asbestos exposure, asbestosis, and asbestos-attributable lung cancer. Thorax 1996, 51, 9–15. Available online: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1090700&tool=pmcentrez&rendertype=abstract (accessed on 1 February 2022). [CrossRef] [PubMed] [Green Version]
Figure 1. Directed acyclic graph illustrating the relationship among potential risk factors and lung cancer collected in the study.
Figure 1. Directed acyclic graph illustrating the relationship among potential risk factors and lung cancer collected in the study.
Ijerph 19 06752 g001
Figure 2. Flow diagram showing recruitment, inclusion and exclusion of participants for the study.
Figure 2. Flow diagram showing recruitment, inclusion and exclusion of participants for the study.
Ijerph 19 06752 g002
Table 1. Frequency of general and clinical characteristics of lung cancer cases and controls participating in the study (n = 234).
Table 1. Frequency of general and clinical characteristics of lung cancer cases and controls participating in the study (n = 234).
Characteristics/CategoryCases
N (%)
Controls
N (%)
Crude OR
(95% CI)
p-Value
Total no 75159
Age
Mean ± SD (range)±61.8 (13.9)±54.8 (14.4)
21–397 (9.3)16 (10.1)-
40–498 (10.7)48 (30.2)0.38 (0.12–1.22)<0.001
50–5912 (16.0)40 (25.2)0.69 (0.23–2.06)
60–6925 (33.3)32 (20.1)1.79 (0.64–5.01)
70+23 (30.7)23 (14.5)2.29 (0.79–6.60)
Gender
Female27(36.0)63(39.6)-
Male48 (64.0)96 (60.4)1.17 (0.66–2.06)0.595
Race
African43 (57.3)135 (84.9)-
Mixed race0 (0)2 (1.26)-
White10 (13.3)9 (5.7)3.49 (1.33–9.14))<0.001
Asian22 (29.3)13 (8.2)5.31 (2.47–11.4)
a Marital status
Single17 (23.3)69 (44.5)-
Married42 (57.5)67 (43.2)2.54 (1.32–4.90)0.004
Divorced + Widowed14 (19.2)19 (12.3)2.99 (1.25–7.14)
b Education
No education—Primary20 (30.3)40 (29.0)-
High school—Higher education46 (69.7)98 (71.0)0.94 (0.49–1.78)0.847
c Monthly household income0–R400044 (71.0)77 (74.0)-
R4 001+18 (29.0)27 (26.0)1.17 (0.58–2.35)0.667
Clinical characteristics of cases
Basis of diagnosis
Biopsy56 (74.7)-
x-ray10 (13.4)---
CT Scan6 (8.00)-
Cytology3 (4.00)
d Histological classification --
Adenocarcinoma16 (21.3)-
Squamous Cell Carcinoma11 (14.7)-
Other 9 (12)-
Staging
11 (1.33)-
20 (0.00)---
32 (2.67)-
428 (37.3)-
Unknown44 (58.7)-
Some variables had “unknown and or participants refused to answer”; therefore, data analysis was conducted on incomplete dataset of those variables; In bold: p-value of ≤ 0.05, a: n = 228; b: n = 204; c: n = 166; d: n = 36.
Table 2. Frequency of occurrence of lifestyle, occupational and environmental risk factors of lung cancer amongst the cases and controls (n = 234).
Table 2. Frequency of occurrence of lifestyle, occupational and environmental risk factors of lung cancer amongst the cases and controls (n = 234).
Variables Cases
n = 75 (%)
Controls
n = 159 (%)
OR (95% CI)p-Value
Lifestyle
Passive smoke exposureNo34 (45.3)112 (70.4)-
Yes41 (54.7)47 (29.6)2.87 (1.63–5.07)<0.001
Have you ever smokedNo26 (34.7)102 (64.2)-
Yes49 (65.3)57 (35.9)3.37 (1.90–6.00)<0.001
Have you ever consumed alcohol?No50 (66.7)93 (58.5)Ref
Yes25 (33.3)66 (41.5)2.82 (1.59–5.00)<0.001
Family history with cancer
Biological fatherNo73 (97.3)158 (99.4)-
Yes2 (2.67)1 (0.63)4.33 (0.39–48.50)0.235
Biological motherNo69 (92.0)155 (97.5)-
Yes6 (8.00)4 (2.52)3.37 (0.92–12.30)0.066
SiblingsNo64 (85.3)156 (98.1)-
Yes11 (14.7)3 (1.89)8.93 (2.41–33.10)0.001
* History of lung diseaseNo53 (70.7)151 (95.0)-
Yes22 (29.3)8 (5.03)7.83 (3.29–18.7)<0.001
Employment sector
Office and HouseholdNo29 (38.7)51 (32.1)-
Yes46 (61.3)108 (67.9)0.75 (0.42–1.33)(0.322)
Transport, Storage and Repair of motor vehiclesNo59 (78.7)146 (91.8)-
Yes16 (21.3)13 (8.18)3.05 (1.38–6.72)(0.006)
* Mining, Construction and ManufacturingNo40 (53.3)113 (71.1)-
Yes35 (46.7)46 (28.9)2.15 (1.22–3.79)(0.008)
Agriculture, Forestry and FishingNo65 (86.7)151 (95.0)-
Yes10 (13.3)8 (5.03)2.90 (1.09–7.69)(0.032)
Occupational exposures
SootNo68 (90.7)157 (98.7)-
Yes7 (9.33)2 (1.26)8.08 (1.64–39.9)(0.010)
Iron and SteelNo67 (89.3)157 (98.7)-
Yes8 (10.7)2 (1.26)9.37 (1.94–45.3)(0.005)
p-value of ≤ 0.05, Significant OR and 95 % CI were marked in bold style; * Mining was not classified according to minerals mined, e.g., coal, asbestos, etc.
Table 3. Associated risk factors in different logistic models for tobacco smoke and passive smoke exposure.
Table 3. Associated risk factors in different logistic models for tobacco smoke and passive smoke exposure.
VariableUnivariate
OR (95%CI)
Multivariate Models
aOR (95% CI)
Tobacco SmokingPassive Smoke Exposure
Tobacco smokingNo -
Yes* 3.37 (1.90–6.00)
(<0.001)
** 2.86 (1.21–6.77)
(0.017)
-
Passive smoke exposureNo -
Yes * 2.87 (1.63–5.07)
(<0.001)
-** 3.28 (1.48–7.30)
(0.004)
Alcohol consumptionNo
Yes * 2.82 (1.59–5.01)
(<0.001)
** 2.79 (1.21–6.41)
(0.016)
** 3.35 (1.44–7.75)
(0.005)
Sibling with cancerNo
Yes** 8.94 (2.41–33.1)
(0.001)
3.83 (0.53–27.4)
(0.181)
3.79 (0.49–29.2)
(0.201)
* History of lung diseaseNo
Yes* 7.83 (3.29–18.7)
(<0.001)
* 9.91 (3.04–32.3)
(<0.001)
* 12.1 (3.72–39.7)
(<0.001)
All multivariate models were adjusted for age, gender, race, marital status, education, alcohol consumption, sibling and history of lung cancer disease; OR: odds ratio; aOR: adjusted odds ratio; * History of lung disease (tuberculosis, asthma, pneumonia or chronic bronchitis); ** p-value < 0.001; * p-value < 0.05; p-value of ≤ 0.05, Significant OR& aOR and 95 % CI were marked in bold style.
Table 4. Crude and adjusted odds ratio of different logistic models of lung cancer associated with different occupational risk factors.
Table 4. Crude and adjusted odds ratio of different logistic models of lung cancer associated with different occupational risk factors.
VariablesUnivariate
OR (95% CI)
Multivariate
aOR (95%CI)
Office and HouseholdTransport, Storage and Repair of Motor VehiclesMining, Construction and ManufacturingAgriculture, Forestry and Fishing
Office and HouseholdNo ---
Yes0.75 (0.42–1.33)
(0.322)
0.69 (0.30–1.62)
(0.395)
---
Transport, Storage and repair of motor vehiclesNo - --
Yes* 3.05 (1.38–6.72)
(0.006)
-1.63 (0.54–4.94)
(0.387)
--
Mining, Construction and ManufacturingNo -- -
Yes* 2.15 (1.22–3.80)
(0.008)
--* 2.64 (1.16–6.01)
(0.020)
-
Agriculture, forestry and fishingNo --
Yes* 2.90 (1.10–7.69)
(0.032)
-- 3.69 (0.95–14.3)
(0.059)
Alcohol consumptionNo
Yes ** 2.82 (1.59–5.01)
(<0.001)
* 2.85 (1.23–6.60)
(0.015)
* 2.72 (1.18–6.29)
(0.019)
* 2.81 (1.19–6.60)
(0.018)
* 2.76 (1.19–6.43)
Sibling with cancerNo
Yes* 8.94 (2.41–33.1)
(0.001)
3.55 (0.51–24.8)
(0.202)
3.30 (0.44–24.9)
(0.246)
4.25 (0.61–29.6)
(0.144)
4.23 (0.59–30.1)
(0.150)
a History of Lung diseaseNo
Yes* 7.83 (3.29–18.7)
(<0.001)
* 10.6 (3.20–35.2)
(<0.001)
* 9.63 (2.98–31.1)
(<0.001)
* 9.73 (2.96–32.0)
(<0.001)
* 9.98 (3.02–33.0)
(<0.001)
Tobacco smokingNo
Yes* 3.37 (1.90–6.00)
(<0.001)
** 2.83 (1.19–6.70)
(0.018)
** 2.86 (1.20–6.82)
(0.017)
** 2.90 (1.20–7.00)
(0.018)
** 2.86 (1.19–6.83)
(0.018)
All multivariate models were adjusted for age, gender, race, marital status, education, alcohol consumption, sibling, history of lung disease and smoking of tobacco; OR: odds ratio; aOR: adjusted odds ratio; a History of lung disease (tuberculosis, asthma, pneumonia or chronic bronchitis); ** p-value < 0.001; * p-value < 0.05; p-value of ≤ 0.05, Significant OR& aOR and 95 % CI were marked in bold style.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Mbeje, N.P.; Ginindza, T.; Jafta, N. Epidemiological Study of Risk Factors for Lung Cancer in KwaZulu-Natal, South Africa. Int. J. Environ. Res. Public Health 2022, 19, 6752. https://doi.org/10.3390/ijerph19116752

AMA Style

Mbeje NP, Ginindza T, Jafta N. Epidemiological Study of Risk Factors for Lung Cancer in KwaZulu-Natal, South Africa. International Journal of Environmental Research and Public Health. 2022; 19(11):6752. https://doi.org/10.3390/ijerph19116752

Chicago/Turabian Style

Mbeje, Noluthando P., Themba Ginindza, and Nkosana Jafta. 2022. "Epidemiological Study of Risk Factors for Lung Cancer in KwaZulu-Natal, South Africa" International Journal of Environmental Research and Public Health 19, no. 11: 6752. https://doi.org/10.3390/ijerph19116752

APA Style

Mbeje, N. P., Ginindza, T., & Jafta, N. (2022). Epidemiological Study of Risk Factors for Lung Cancer in KwaZulu-Natal, South Africa. International Journal of Environmental Research and Public Health, 19(11), 6752. https://doi.org/10.3390/ijerph19116752

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop